These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37392418)

  • 1. Myoclonus in patients with COVID-19: Findings of autoantibodies against brain structures in cerebrospinal fluid.
    Lindqvist I; Cunningham JL; Mulder J; Feresiadou A; Rostami E; Virhammar J; Kumlien E
    Eur J Neurol; 2023 Oct; 30(10):3142-3148. PubMed ID: 37392418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.
    Franke C; Ferse C; Kreye J; Reincke SM; Sanchez-Sendin E; Rocco A; Steinbrenner M; Angermair S; Treskatsch S; Zickler D; Eckardt KU; Dersch R; Hosp J; Audebert HJ; Endres M; Ploner JC; Prüß H
    Brain Behav Immun; 2021 Mar; 93():415-419. PubMed ID: 33359380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of antineuronal autoantibodies in a series of neurological patients.
    Vianello M; Vitaliani R; Pezzani R; Nicolao P; Betterle C; Keir G; Thompson EJ; Tavolato B; Scaravilli F; Giometto B
    J Neurol Sci; 2004 May; 220(1-2):29-36. PubMed ID: 15140602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders.
    Endres D; von Zedtwitz K; Matteit I; Bünger I; Foverskov-Rasmussen H; Runge K; Feige B; Schlump A; Maier S; Nickel K; Berger B; Schiele MA; Cunningham JL; Domschke K; Prüss H; Tebartz van Elst L
    Biol Psychiatry; 2022 Aug; 92(4):261-274. PubMed ID: 35606187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reversible white matter lesions and antithyroid antibodies in the cerebrospinal fluid in Hashimoto's encephalopathy: a case report].
    Wakai M; Nishikage H; Goshima K
    Rinsho Shinkeigaku; 2004 Jul; 44(7):432-7. PubMed ID: 15384704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
    Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineuronal Autoantibodies in the Cerebrospinal Fluid and Serum From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects.
    Sørensen NV; Nilsson AC; Orlovska-Waast S; Jeppesen R; Christensen RHB; Benros ME
    Biol Psychiatry Glob Open Sci; 2023 Oct; 3(4):1116-1121. PubMed ID: 37881586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review.
    Yiannopoulou K; Vakrakou AG; Anastasiou A; Nikolopoulou G; Sourdi A; Tzartos JS; Kilidireas C; Dimitrakopoulos A
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
    Franke C; Boesl F; Goereci Y; Gerhard A; Schweitzer F; Schroeder M; Foverskov-Rasmussen H; Heine J; Quitschau A; Kandil FI; Schild AK; Finke C; Audebert HJ; Endres M; Warnke C; Prüss H
    Brain Behav Immun; 2023 Mar; 109():139-143. PubMed ID: 36657623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Antineuronal Autoantibodies With Somatodendritic Staining Pattern in a Patient With Autoimmune Psychosis.
    Endres D; Rauer S; Pschibul A; Süß P; Venhoff N; Runge K; Feige B; Denzel D; Nickel K; Schweizer T; Maier S; Egger K; Domschke K; Meyer PT; Prüss H; Tebartz van Elst L
    Front Psychiatry; 2020; 11():627. PubMed ID: 32848899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and short-term outcomes of autoimmune encephalitis in adults].
    Chekanova EO; Shabalina AA; Zakharova MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7. Vyp. 2):103-115. PubMed ID: 37560842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings.
    Delorme C; Paccoud O; Kas A; Hesters A; Bombois S; Shambrook P; Boullet A; Doukhi D; Le Guennec L; Godefroy N; Maatoug R; Fossati P; Millet B; Navarro V; Bruneteau G; Demeret S; Pourcher V;
    Eur J Neurol; 2020 Dec; 27(12):2651-2657. PubMed ID: 32881133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune encephalitis with anti-glutamate receptor antibody presenting as epilepsia partialis continua and action myoclonus: a case report].
    Kato Y; Nakazato Y; Tamura N; Tomioka R; Takahashi Y; Shimazu K
    Rinsho Shinkeigaku; 2007 Jul; 47(7):429-33. PubMed ID: 17710887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: Cerebrospinal fluid findings from 793 patients.
    Liu T; Chen B; Yang H; Huang J; Liu S; Yang X; Huang L; Yao H; Qiu W; Zhuang H; Long Y; Gao C
    Mult Scler Relat Disord; 2019 Feb; 28():177-183. PubMed ID: 30611927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine release syndrome-associated encephalopathy in patients with COVID-19.
    Perrin P; Collongues N; Baloglu S; Bedo D; Bassand X; Lavaux T; Gautier-Vargas G; Keller N; Kremer S; Fafi-Kremer S; Moulin B; Benotmane I; Caillard S
    Eur J Neurol; 2021 Jan; 28(1):248-258. PubMed ID: 32853434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diaphragmatic myoclonus due to SARS-CoV-2 infection.
    Borroni B; Gazzina S; Dono F; Mazzoleni V; Liberini P; Carrarini C; Russo M; Pontolillo M; Vecchiet J; Onofrj M; Bonanni L
    Neurol Sci; 2020 Dec; 41(12):3471-3474. PubMed ID: 33090303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.
    Bartley CM; Johns C; Ngo TT; Dandekar R; Loudermilk RL; Alvarenga BD; Hawes IA; Zamecnik CR; Zorn KC; Alexander JR; Wapniarski AE; DeRisi JL; Francisco C; Nash KB; Wietstock SO; Pleasure SJ; Wilson MR
    JAMA Neurol; 2021 Dec; 78(12):1503-1509. PubMed ID: 34694339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.